TRIUS THERAPEUTICS
Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. We have successfully completed two Phase 3 clinical trials for Tedizolid Phosphate (TR-701), formerly torezolid phosphate, in ABSSSI. Tedizolid is an IV and orally administered second generation oxazolidinone, for the treatment of serious gram-positive bacterial infections, including those caused by methicillin-resistant Staph... ylococcus aureus (MRSA). With the continuous increase in bacterial resistance to currently marketed drugs, serious infections are becoming more difficult, if not impossible to treat, and this has led to a clear need for novel therapeutics to treat multi-drug resistant bacterial infections. Trius is headquartered in San Diego, California. We have built a strong management team with significant development and regulatory experience. Our senior management team consists of nine individuals who collectively have been involved in the development and approval of a significant number of anti-infective drugs.
TRIUS THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care
Founded:
2004-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.triusrx.com
Total Employee:
1001+
Status:
Closed
Contact:
8586779975
Total Funding:
99.25 M USD
Technology used in webpage:
Euro Nginx OpenResty Google Adsense Google Adsense For Domains IIS 6 Time Warner LeaseWeb Omniture SiteCatalyst Charter Communications
Similar Organizations
BiomeHub
BiomeHub focuses on the development of innovative healthcare services.
Nexcida Therapeutics
Nexcida Therapeutics develops a novel antibiotics to treat serious, life-threatening bacterial infections.
Saegis Pharmaceuticals
Saegis Pharmaceuticals is focused on the development of medicines that address behavioral disorders.
Zolex Therapeutics
Zolex Therapeutics focuses on the development of new classes of orally-active antibiotics to combat life-threatening bacterial infections.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Versant Ventures
Versant Ventures investment in Series A - Trius Therapeutics
InterWest Partners
InterWest Partners investment in Series A - Trius Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series A - Trius Therapeutics
Tech Coast Angels
Tech Coast Angels investment in Venture Round - Trius Therapeutics
